De novo design of potent and selective interleukin mimetics
US11117944B2 · kind B2 · utility
4Cited by
6References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 18, 2020 |
| Grant date | Sep 14, 2021 |
| Priority date | — |
| Expiry date | Jun 18, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
De novo designed polypeptides that bind to IL-2 receptor βγc heterodimer (IL-2Rβγc), IL-4 receptor αγc heterodimer (IL-4Rαγc), or IL-13 receptor α subunit (IL-13Rα) are disclosed, as are methods for using and designing the polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.